Even Though ApicHope Pharmaceutical Group (SZSE:300723) Has Lost CN¥660m Market Cap in Last 7 Days, Shareholders Are Still up 47% Over 5 Years

Simply Wall StMar 21 20:12 ET

Subdued Growth No Barrier To ApicHope Pharmaceutical Group Co., Ltd. (SZSE:300723) With Shares Advancing 30%

Simply Wall StFeb 22 19:22 ET

ApicHope Pharmaceutical (300723.SZ) plans to launch an incentive plan for no more than 7.652 million Stocks Options.

ApicHope Pharmaceutical (300723.SZ) disclosed the draft of the 2025 Stocks Options incentive plan, this incentive plan...

Zhitong FinanceFeb 10 06:36 ET

Private Companies Are ApicHope Pharmaceutical Group Co., Ltd.'s (SZSE:300723) Biggest Owners and Were Rewarded After Market Cap Rose by CN¥467m Last Week

Simply Wall StFeb 7 18:49 ET

Poinsettia: 2024 performance forecast

SZSIJan 22 11:00 ET · Announcements

Involved in the "first major bidding case of national procurement", ApicHope Pharmaceutical may face its first loss after going public | Interpretations

① Due to the continued increase in research and development investment, reimbursement of medical insurance refunds, and other factors, ApicHope Pharmaceutical may experience its first loss since its listing in 2024. ② It is expected that the net loss in Q4 will be between 0.225 billion yuan and 0.433 billion yuan.

cls.cnJan 22 10:27 ET